Fax:
203.504.7700

Send A Message:
Connecticut Physical Medicine Office in Waterbury Connecticut

Medical Marijuana Cards

Hartford, CT | Waterbury, CT

Medical research has shown medical marijuana helpful in the management of a wide range of symptoms. Symptoms and conditions where medical marijuana shows promise include neuropathic pain, Parkinson's, intractable headache, and spine injuries - to name a few. As of 2020, Connecticut's Department of Consumer Protection has approved medical marijuana for the treatment of 38 conditions for adults and ten conditions for patients under age 18. In some cases, medical marijuana has a unique pharmacological action which makes it effective in ways that are out of reach of other medications. In other cases, synthetic medications are available, but the side effects and risks of medical marijuana may be preferable. Medical marijuana has been used to reduce or replace the use of opioids, benzodiazeines, and dopamine antagonists such as haloperidol and olanzapine.


Our Process

Connecticut Physical Medicine has certification in medical marijuana. We can provide annual certification for medical marijuana cards issued by the state of Connecticut. Patients take medical marijuana as part of treatment for debilitating conditions. For medical marijuana certification, patients must be Connecticut residents and have a condition approved by state authorities.


Conditions for Which Medical Marijuana is Approved

(Updated 10-24-20)

Medical Marijuana for Adults

Cancer (Effective 2012)

Glaucoma (Effective 2012)

Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome (Effective 2012)

Parkinson's Disease (Effective 2012)

Multiple Sclerosis (Effective 2012)

Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012)

Epilepsy (Effective 2012)

Cachexia (Effective 2012)

Wasting Syndrome (Effective 2012)

Crohn's Disease (Effective 2012)

Post-Traumatic Stress Disorder (Effective 2012)

Sickle Cell Disease (Effective 2016)

Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)

Severe Psoriasis and Psoriatic Arthritis (Effective 2016)

Amyotrophic Lateral Sclerosis (Effective 2016)

Ulcerative Colitis (Effective 2016)

Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)

Cerebral Palsy (Effective 2016)

Cystic Fibrosis (Effective 2016)

Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016)

Terminal Illness Requiring End-Of-Life Care (Effective 2016)

Uncontrolled Intractable Seizure Disorder (Effective 2016)

Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)

Severe Rheumatoid Arthritis (Effective 2018)

Post Herpetic Neuralgia (Effective 2018)

Hydrocephalus with Intractable Headache (Effective 2018)

Intractable Headache Syndromes (Effective 2018)

Neuropathic Facial Pain (Effective 2018)

Muscular Dystrophy (Effective 2018)

Osteogenesis Imperfecta (Effective 2018)

Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)

Interstitial Cystitis (Effective 2019)

MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)

Vulvodynia and Vulvar Burning (Effective 2019)

Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)

Tourette's Syndrome (Effective 2019)

Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)

Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)

Medical Marijuana for Patients Under Age 18

Cerebral Palsy (Effective 2016)

Cystic Fibrosis (Effective 2016)

Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity (Effective 2016)

Severe Epilepsy (Effective 2016)

Terminal Illness Requiring End-Of-Life Care (Effective 2016)

Uncontrolled Intractable Seizure Disorder (Effective 2016)

Muscular Dystrophy (Effective 2018)

Osteogenesis Imperfecta (Effective 2018)

Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)

Tourette's Syndrome for patients who have failed standard medical treatment (Effective 2019)



Don't procrastinate. Contact us now for an appointment, and let's explore your options for feeling better. Call now: 203.437.7229
Send a message.

Name:
Email:
Phone:

Message:

SPAM CHECK: What is 1 plus 1?


close Call Now
203.437.7229
Send a Message